COVID-19 and the Future of Cardiac Care

From the Lasting Effects on Stroke and Heart Attack Patients Who Do Not Seek Care to How to Resume Cardiac Surgery, Cedars-Sinai Expert Provides Forecast for the Future of Care

Newswise — LOS ANGELES (June 18, 2020) - As Cedars-Sinai expands telehealth and video visits and resumes surgeries, Joanna Chikwe, MD, chair of the Department of Cardiac Surgery at the Smidt Heart Institute, has her focus on one thing: ensuring that patients with heart disease understand it is safe to be seen, and treated, by Cedars-Sinai healthcare teams.

In three recent publications, Chikwe describes how flattening the COVID-19 curve has come at a "terrible cost" for patients with heart conditions. Chikwe also outlines how surgeons, hospitals and ambulatory care centers can safely resume caring for cardiac surgery patients in the era of the virus. 

"Patients are now scared to go to their primary care doctors, their cardiologists' offices and the emergency room, where admissions are down by over 70% in many institutions," reads an article Chikwe co-authored with Christine Albert, MD, MPH, chair of the Department of Cardiology. The article was published in Cardiology, a publication of the American College of Cardiology. "There is no way of knowing how many patients are dying at home of cardiac causes unrelated to COVID-19 because they have delayed seeking medical attention." 

The finding that cardiac admissions are down by over 70% in many institutions comes from a published paper in the journal Circulation, of which Chikwe served as an author. 

In the study, researchers surveyed 60 cardiac surgery centers in North and South America, Europe, Asia and Australia during the peak of the COVID-19 pandemic. The survey represented over 600 cardiac surgeons and found the median reduction in cardiac surgery case volume was 50% to 75%, with many centers indicating their surgeons were not performing any elective surgeries. 

As a follow-up to the study, Chikwe served as lead author on new recommendations published in the Annals of Thoracic Surgery that provide guidance around safely resuming cardiac surgery, research and education amid COVID-19.

The recommendations were developed by committee discussion within a cardiovascular research consortium representing 19 countries and a broad spectrum of cardiac surgery experience. The authors recommended that cardiac surgery be among the first clinical services supported so that elective inpatient and outpatient care can be resumed as soon as possible. Additionally, all patients should be screened for COVID-19 prior to surgery.

"Our practical recommendations are intended to support local decision-making according to governmental requirements, regional disease prevalence, institutional capacity and ethics," said Chikwe.

Cedars-Sinai staff has already implemented the key recommendations in the consensus statements, including testing before every procedure.

"State-of-the-art screening and prevention services at Cedars-Sinai create a safe environment for the highest quality cardiac care," said Eduardo Marbán, MD, PhD, executive director if the Smidt Heart Institute. "We are committed to ensuring that patients in need not delay seeking treatment for fear of contracting COVID-19." 

Before and after procedures, as much as possible is now being done remotely, to save patients the risk and expense of in-person visits.

"Above all, we want all patients – especially those with cardiac care needs – to know it's safe and easier than ever to see your doctor and get the treatment you need," said Chikwe.

More information for patients and visitors is available here.

Read more on the Cedars-Sinai Blog: The Race to Develop a Vaccine for COVID-19.


Filters close

Showing results

110 of 3446
Released: 29-Sep-2020 7:05 PM EDT
Research into SARS-CoV-2 mutation “hotspots” raises implications for vaccines and therapeutics
UCLA Fielding School of Public Health

Researchers have found at least 10 distinct “hotspot” mutations in more than 80% of randomly selected SAR-CoV-2 sequences from six countries, and these genome hotspots – seen as "typos" that can occur as the virus replicates during cellular division – could have a significant impact in the fight against the COVID-19 pandemic.

Newswise: New “Buzz” about Fighting COVID-19 at Baltimore-Area Barbershops
Released: 29-Sep-2020 6:30 PM EDT
New “Buzz” about Fighting COVID-19 at Baltimore-Area Barbershops
LifeBridge Health

LifeBridge Health Partners with Live Chair Health to Offer Coronavirus Support And Expansion of Barbershop Health Screening Program

access_time Embargo lifts in 2 days
Embargo will expire: 30-Sep-2020 7:05 PM EDT Released to reporters: 29-Sep-2020 5:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Sep-2020 7:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Eccles School Launches Postdoctoral Program in Entrepreneurship & Strategy
Released: 29-Sep-2020 4:45 PM EDT
Eccles School Launches Postdoctoral Program in Entrepreneurship & Strategy
University of Utah, David Eccles School of Business

The Department of Entrepreneurship & Strategy at the University of Utah’s David Eccles School of Business launched a new postdoctoral fellowship program with the hire of Maria Kurakina, a young scholar with a Ph.D. from the University of California at Berkeley, Haas School of Business.

Released: 29-Sep-2020 4:35 PM EDT
Study supports airborne spread of COVID-19 indoors
University of Georgia

New research from the University of Georgia supports growing evidence for airborne transmission of COVID-19 in enclosed spaces.

Newswise: 244300_web.jpg
Released: 29-Sep-2020 3:35 PM EDT
Conversation quickly spreads droplets inside buildings
Princeton University School of Engineering and Applied Science

With implications for the transmission of diseases like COVID-19, researchers have found that ordinary conversation creates a conical 'jet-like' airflow that quickly carries a spray of tiny droplets from a speaker's mouth across meters of an interior space.

Released: 29-Sep-2020 2:25 PM EDT
VirScan offers new insights into COVID-19 antibody response
Brigham and Women’s Hospital

A tool designed to detect viral history in a drop of blood has gotten an upgrade in the age of COVID-19.

Newswise: 244362_web.jpg
Released: 29-Sep-2020 1:50 PM EDT
In a field where smaller is better, researchers discover the world's tiniest antibodies
University of Bath

Researchers at the University of Bath in the UK and biopharma company UCB have found a way to produce miniaturised antibodies, opening the way for a potential new class of treatments for diseases.

Showing results

110 of 3446